Rss Feed

Subscribe to Rss Feed feed
Latest Medical Research News and Research
Updated: 59 min 16 sec ago

New software found to be four times better at predicting the prognosis of ovarian cancer

Mon, 02/18/2019 - 22:07
A new tool has proved to be four times more reliable at predicting prognosis in patients with ovarian cancer and the most effective course of treatment.

Scanning children's teeth may predict future mental health issues

Mon, 02/18/2019 - 20:02
A new study has found that scanning children’s teeth could help to predict their risk of developing mental health problems later in life.

Physicists identify simple mechanism used by deadly bacteria to fend off antibiotics

Mon, 02/18/2019 - 18:51
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into how germs adapt and behave at a level of detail never seen before.

Study: COPD patients need more support when understanding new chest symptoms

Mon, 02/18/2019 - 18:19
People with Chronic Obstructive Pulmonary Disease need more support when understanding and acting on new chest symptoms, a study in the journal Psycho-Oncology reports.

Hormone therapy during gender transition may increase risk for cardiovascular events

Mon, 02/18/2019 - 17:46
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular events, including strokes, heart attacks and blood clots, according to a study published in the American Heart Association's journal Circulation.

How many push-ups can you do? Men who are able to do ten push-ups are less likely to have a stroke

Mon, 02/18/2019 - 17:34
The findings show that middle-aged men who are able to complete 10 push-ups could reduce their risk of heart attack and stroke by as much as 97 percent.

Combination of PARP inhibitor and immunotherapy results in tumor regression in SCLC mouse models

Mon, 02/18/2019 - 13:28
Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

Heavy smoking could lead to vision loss, study finds

Mon, 02/18/2019 - 13:22
Smoking more than 20 cigarettes a day can damage your vision, a study co-authored by a Rutgers researcher finds.

Activating gene that helps excite neurons reverses depression in male mice

Mon, 02/18/2019 - 13:11
Directly activating a gene important to exciting our excitatory neurons and associated with major depression may help turn around classic symptoms like social isolation and loss of interest, at least for males, scientists report.

Study offers implications of advanced age in evaluation, management of ischemic heart disease

Mon, 02/18/2019 - 11:44
Demographic trends worldwide show a progressively aging population and an increase in the overall medical complexity of elderly patients with cardiovascular disease.

Patients with diabetes mellitus have high risk of stable ischemic heart disease

Mon, 02/18/2019 - 11:33
More than 30 million Americans have diabetes mellitus, and heart disease is the cause of death in 68% of them.

Children from homes with flame-retardant sofa have high SVOC concentration in their blood

Mon, 02/18/2019 - 11:23
Children living in homes with all vinyl flooring or flame-retardant chemicals in the sofa have significantly higher concentrations of potentially harmful semi-volatile organic compounds in their blood or urine than children from homes where these materials are not present, according to a new Duke University-led study.

Drug combinations could become first-line treatment for metastatic kidney cancer

Mon, 02/18/2019 - 11:15
A combination of two drugs - one of them an immunotherapy agent - could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

New PET/CT tracer shows high detection rate for diagnosis of acute venous thromboembolism

Mon, 02/18/2019 - 10:58
A first-in-human study featured in the February issue of The Journal of Nuclear Medicine reports that the novel positron emission tomography/computed tomography tracer 18F-GP1 showed excellent image quality and a high detection rate for the diagnosis of acute venous thromboembolism.

Study estimates how common, preventable are sepsis-related deaths in hospitals

Mon, 02/18/2019 - 10:48
This study estimates how common sepsis-related deaths are in hospitals and how preventable those deaths might be.

Smoking may blight immune response against melanoma and reduce survival

Mon, 02/18/2019 - 10:39
Melanoma patients with a history of smoking cigarettes are 40 per cent less likely to survive their skin cancer than people who have never smoked, according to a new report funded by Cancer Research UK.

Scientists identify link between drinking contexts and early onset intoxication among adolescents

Mon, 02/18/2019 - 10:34
Early onset drinking, drinking and intoxication at an early age among adolescents, has been identified as a primary risk for later heavy drinking, alcohol problems, and alcohol dependence among youth and young adults. To prevent or delay early onset drinking, we must know more about the modifiable circumstances that enable these behaviors.

Research finds reasons for sudden cardiac death in patients with stable ischemic disease

Mon, 02/18/2019 - 10:33
Sudden death in patients with stable ischemic heart disease is not a common occurrence and is sparsely reported.

Study sheds new light on left ventricular dysfunction in ischemic heart disease

Mon, 02/18/2019 - 10:22
Ischemic heart disease is a growing cause of heart failure owing to the increasing prevalence of diabetes, hypertension, and obesity.

Columbia researchers unravel why some glioblastomas respond to immunotherapy

Mon, 02/18/2019 - 10:21
Columbia researchers have learned why some glioblastomas--the most common type of brain cancer--respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy drugs and lead to the development of more broadly effective treatments.